Introducing GLP-1 Telehealth for weight loss
Launched on Feb 7, 2024, focusing on accessible weight loss solutions.
Advancing health data democratization and shaping healthcare's future in Web3.
From BMI checks to personalized Semaglutide prescriptions.
A GLP-1 receptor agonist promoting weight loss.
Patientory leads in integrating wearable data with EHR for global health advancement.
2024 Health Equity Business Accelerator Participant with over $325,000 in seed funding.
Embrace the future of health and wellness with Patientory.